Hepatitis C virus

5-Iodo-2-Aminoindan (5-IAI): Chemistry, Pharmacology, and Toxicology of a Research Chemical Producing MDMA-Like Effects.

Published January 26, 2013

5-iodo-2-aminoindan (5-IAI): chemistry, pharmacology, and toxicology of a research chemical producing MDMA-like effects.

Filed under: Addiction Rehab

Toxicol Lett. 2013 Jan 21;
Coppola M, Mondola R

In 2010, an internet snapshot of EMCDDA anticipated the presence of 5-iodo-2-aminoindan (5-IAI)… Continue reading →

Addiction Rehab: Low Incidence of HCV Amongst Prisoners in Scotland.

Published January 11, 2013

Low incidence of HCV amongst prisoners in Scotland.

Filed under: Addiction Rehab

Addiction. 2013 Jan 8;
Taylor A, Munro A, Allen E, Dunleavy K, Cameron S, Miller L, Hickman M

AIMS: To estimate HCV incidence and HCV risk among… Continue reading →

Drug and Alcohol Rehabilitation: Computational Analysis to Predict Functional Role of Hsa-miR-3065-3p as an Antiviral Therapeutic Agent for Treatment of Triple Infections: HCV, HIV-1, and HBV.

Published January 6, 2013

Computational analysis to predict functional role of hsa-miR-3065-3p as an antiviral therapeutic agent for treatment of triple infections: HCV, HIV-1, and HBV.

Filed under: Drug and Alcohol Rehabilitation

Libyan J Med. 2012; 7:
Khokhar A, Noorali S, Sheraz M,… Continue reading →

Novel Anticoagulants in Atrial Fibrillation Stroke Prevention.

Published December 20, 2012

Novel anticoagulants in atrial fibrillation stroke prevention.

Filed under: Drug and Alcohol Rehabilitation

Ther Adv Chronic Dis. 2012 May; 3(3): 123-36
Norgard NB, Dinicolantonio JJ, Topping TJ, Wee B

This review article evaluates novel oral anticoagulants in comparison with… Continue reading →

Safety of Lamivudine Treatment for Chronic Hepatitis B in Early Pregnancy.

Published December 14, 2012

Safety of lamivudine treatment for chronic hepatitis B in early pregnancy.

Filed under: Rehab Centers

World J Gastroenterol. 2012 Dec 7; 18(45): 6645-50
Yi W, Liu M, Cai HD

To evaluate the safety of lamivudine (LAM) treatment for chronic… Continue reading →

Drug and Alcohol Rehabilitation: Clinical Results Between Single Incision Laparoscopic Cholecystectomy and Conventional 3-Port Laparoscopic Cholecystectomy: Prospective Case-Matched Analysis in Single Institution.

Published December 12, 2012

Clinical results between single incision laparoscopic cholecystectomy and conventional 3-port laparoscopic cholecystectomy: prospective case-matched analysis in single institution.

Filed under: Drug and Alcohol Rehabilitation

J Korean Surg Soc. 2012 Dec; 83(6): 374-80
Jung GO, Park DE, Chae KM

The… Continue reading →

Addiction Rehab: Does Alcoholics Anonymous Work Differently for Men and Women? a Moderated Multiple-Mediation Analysis in a Large Clinical Sample.

Published December 5, 2012

Does Alcoholics Anonymous work differently for men and women? A moderated multiple-mediation analysis in a large clinical sample.

Filed under: Addiction Rehab

Drug Alcohol Depend. 2012 Nov 30;
Kelly JF, Hoeppner BB

BACKGROUND: Alcoholics Anonymous (AA) began as a… Continue reading →

Patterns of Cocaine and Opioid Co-Use and Polyroutes of Administration Among Street-Based Cocaine Users in Montréal, Canada.

Published November 28, 2012

Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada.

Filed under: Addiction Rehab

Int J Drug Policy. 2012 Nov 22;
Roy E, Richer I, Arruda N, Vandermeerschen J, Bruneau J

BACKGROUND:… Continue reading →

Predictors of Sleep Quality in Community-Dwelling Older Adults in Northern Taiwan.

Published November 17, 2012

Predictors of sleep quality in community-dwelling older adults in northern taiwan.

Filed under: Depression Treatment

J Nurs Res. 2012 Dec; 20(4): 249-60
Yang CY, Chiou AF

: Poor sleep quality may have a significant and negative impact on physical… Continue reading →

Drug and Alcohol Rehabilitation: Galactosylated Chitosan/5-Fluorouracil Nanoparticles Inhibit Mouse Hepatic Cancer Growth and Its Side Effects.

Published November 17, 2012

Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Filed under: Drug and Alcohol Rehabilitation

World J Gastroenterol. 2012 Nov 14; 18(42): 6076-87
Cheng MR, Li Q, Wan T, He B, Han J, Chen HX, Yang… Continue reading →

5-Iodo-2-Aminoindan (5-IAI): Chemistry, Pharmacology, and Toxicology of a Research Chemical Producing MDMA-Like Effects.

Addiction Rehab: Low Incidence of HCV Amongst Prisoners in Scotland.

Drug and Alcohol Rehabilitation: Computational Analysis to Predict Functional Role of Hsa-miR-3065-3p as an Antiviral Therapeutic Agent for Treatment of Triple Infections: HCV, HIV-1, and HBV.

Novel Anticoagulants in Atrial Fibrillation Stroke Prevention.

Drug and Alcohol Rehabilitation: Clinical Results Between Single Incision Laparoscopic Cholecystectomy and Conventional 3-Port Laparoscopic Cholecystectomy: Prospective Case-Matched Analysis in Single Institution.

Patterns of Cocaine and Opioid Co-Use and Polyroutes of Administration Among Street-Based Cocaine Users in Montréal, Canada.

Predictors of Sleep Quality in Community-Dwelling Older Adults in Northern Taiwan.

Drug and Alcohol Rehabilitation: Galactosylated Chitosan/5-Fluorouracil Nanoparticles Inhibit Mouse Hepatic Cancer Growth and Its Side Effects.

Recent Posts

Search this Site